NASDAQ:LIFE - aTyr Pharma Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.5731 +0.01 (+1.78 %) (As of 01/20/2019 03:20 PM ET)Previous Close$0.5731Today's Range$0.5610 - $0.607552-Week Range$0.38 - $4.13Volume165,302 shsAverage Volume311,393 shsMarket Capitalization$17.21 millionP/E Ratio-0.31Dividend YieldN/ABeta2.6 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email aTyr Pharma, Inc., a clinical stage biotechnology company, engages in the discovery and development of medicines for the treatment of cancer and lung disease in the United States. The company's therapeutic candidate pipeline that includes ATYR1923 candidate, an agonist of the Resokine pathway that is in Phase I clinical trial designed to temper immune engagement in interstitial lung diseases; and ORCA program, a preclinical research stage program that targets immuno-oncology pathway using antibodies to enhance the immune response in tumor settings. It is also developing ATYR1940, a therapeutic candidate based on a protein naturally secreted from muscle for the treatment of facioscapulohumeral muscular dystrophy, limb-girdle muscular dystrophy, and duchenne muscular dystrophy. aTyr Pharma, Inc. was founded in 2005 and is headquartered in San Diego, California. Receive LIFE News and Ratings via Email Sign-up to receive the latest news and ratings for LIFE and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Biological products, except diagnostic Sub-IndustryLife Sciences Tools & Services SectorMedical Current SymbolNASDAQ:LIFE Previous Symbol CUSIP53217V10 Webwww.atyrpharma.com Phone858-731-8389Debt Debt-to-Equity Ratio0.26 Current Ratio5.38 Quick Ratio5.38Price-To-Earnings Trailing P/E Ratio-0.31 Forward P/E Ratio-0.51 P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$2.16 per share Price / Book0.27Profitability EPS (Most Recent Fiscal Year)($1.87) Net Income$-48,200,000.00 Net MarginsN/A Return on Equity-78.13% Return on Assets-53.62%Miscellaneous Employees65 Outstanding Shares30,020,000Market Cap$17.21 million OptionableOptionable aTyr Pharma (NASDAQ:LIFE) Frequently Asked Questions What is aTyr Pharma's stock symbol? aTyr Pharma trades on the NASDAQ under the ticker symbol "LIFE." How were aTyr Pharma's earnings last quarter? aTyr Pharma Inc (NASDAQ:LIFE) posted its quarterly earnings results on Tuesday, November, 13th. The biotechnology company reported ($0.24) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.30) by $0.06. View aTyr Pharma's Earnings History. When is aTyr Pharma's next earnings date? aTyr Pharma is scheduled to release their next quarterly earnings announcement on Monday, March 18th 2019. View Earnings Estimates for aTyr Pharma. What price target have analysts set for LIFE? 4 brokers have issued 12-month price objectives for aTyr Pharma's shares. Their forecasts range from $0.75 to $1.80. On average, they expect aTyr Pharma's share price to reach $1.1833 in the next twelve months. This suggests a possible upside of 106.5% from the stock's current price. View Analyst Price Targets for aTyr Pharma. What is the consensus analysts' recommendation for aTyr Pharma? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for aTyr Pharma in the last year. There are currently 1 sell rating, 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for aTyr Pharma. Has aTyr Pharma been receiving favorable news coverage? News coverage about LIFE stock has been trending extremely positive on Sunday, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. aTyr Pharma earned a media sentiment score of 4.1 on InfoTrie's scale. They also assigned media headlines about the biotechnology company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next few days. Who are some of aTyr Pharma's key competitors? Some companies that are related to aTyr Pharma include AVITA MED LTD/S (AVMXY), BioCardia (BCDA), Outlook Therapeutics (OTLK), Applied Genetic Technologies (AGTC), Genocea Biosciences (GNCA), Proteon Therapeutics (PRTO), Oncobiologics (ONS), Arsanis (ASNS), Entera Bio (ENTX), Curis (CRIS), BIONDVAX PHARMA/S (BVXV), TRACON Pharmaceuticals (TCON), Microbot Medical (MBOT), CytRx (CYTR) and Vical (VICL). Who are aTyr Pharma's key executives? aTyr Pharma's management team includes the folowing people: Dr. Sanjay S. Shukla, Pres, CEO & Director (Age 47)Dr. David J. King, Chief Scientific Officer (Age 60)Dr. John D. Mendlein, Strategic Advisor & Director (Age 59)Dr. Sanuj K. Ravindran, Bus. Advisor (Age 47)Xiang-Lei Yang Ph.D., Founder When did aTyr Pharma IPO? (LIFE) raised $76 million in an initial public offering (IPO) on Thursday, May 7th 2015. The company issued 5,400,000 shares at $13.00-$15.00 per share. J.P. Morgan and Citigroup acted as the underwriters for the IPO and BMO Capital Markets and William Blair were co-managers. How do I buy shares of aTyr Pharma? Shares of LIFE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is aTyr Pharma's stock price today? One share of LIFE stock can currently be purchased for approximately $0.5731. How big of a company is aTyr Pharma? aTyr Pharma has a market capitalization of $17.21 million. The biotechnology company earns $-48,200,000.00 in net income (profit) each year or ($1.87) on an earnings per share basis. aTyr Pharma employs 65 workers across the globe. What is aTyr Pharma's official website? The official website for aTyr Pharma is http://www.atyrpharma.com. How can I contact aTyr Pharma? aTyr Pharma's mailing address is 3545 JOHN HOPKINS COURT SUITE 250, SAN DIEGO CA, 92121. The biotechnology company can be reached via phone at 858-731-8389 or via email at [email protected] MarketBeat Community Rating for aTyr Pharma (NASDAQ LIFE)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 324 (Vote Outperform)Underperform Votes: 393 (Vote Underperform)Total Votes: 717MarketBeat's community ratings are surveys of what our community members think about aTyr Pharma and other stocks. Vote "Outperform" if you believe LIFE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LIFE will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/20/2019 by MarketBeat.com StaffFeatured Article: What is the Dividend Aristocrat Index?